Prominent Rochester Physician Files Lawsuit Against Mayo Clinic
He claims he unlawfully faced retaliation as a whistleblower and discipline for comments made in media interviews.
Source: krocnews.com
Page 3 - Us Expanded Access Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Us Expanded Access Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Us Expanded Access Program Today - Breaking & Trending Today
Ascendis Pharma A/S (NASDAQ:ASND) Q2 2023 Earnings Call Transcript
Ascendis Pharma A/S (NASDAQ:ASND) Q2 2023 Earnings Call Transcript September 5, 2023 Ascendis Pharma A/S beats earnings expectations. Reported EPS is $2.16, expectations were $-2.68. Operator: Hello, and welcome to Ascendis Pharma Q2 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a […]
Source: yahoo.com
Gilead Announces Partial Clinical Hold for Magrolimab Studies in AML
– Enrolled Patients May Continue Receiving Study Medicine – – Studies in Solid Tumors Unaffected – ...
Source: marketscreener.com
FDA Pauses Gilead's Investigational Magrolimab Study In Blood Cancer Patients - Gilead Sciences (NASDAQ:GILD)
FDA has placed a partial clinical hold on Gilead Sciences Inc (NASDAQ: GILD) initiation of new patients in U.S.
Source: benzinga.com
FDA Places Second Partial Clinical Hold on AML Enrollment for Magrolimab Trials
The FDA has placed another partial clinical hold on the enrollment of new patients in United States clinical trials evaluating the potential first-in-class investigational anti-CD47 immunotherapy magrolimab for the treatment of acute myeloid leukemia.
Source: onclive.com